Innovative Diagnostic Platform Biological Dynamics has developed the ExoVerita platform, a cutting-edge exosome-isolation technology aimed at early disease detection, opening opportunities to collaborate with healthcare providers and labs seeking advanced diagnostic solutions.
Strong Funding & Growth With over $75 million raised and recent product launches, the company is positioned for expansion into new markets and collaborations with clinical research organizations, providing avenues for partnership and contract research services.
Strategic Partnerships Active collaborations with academic and medical institutions like Oregon Health & Science University demonstrate an openness to joint research and validation projects, presenting sales prospects for instrumentation, assay kits, and support services.
Market Focus & Potential Targeting early detection of high-burden cancers such as pancreatic ductal adenocarcinoma, biological dynamics offers opportunities to engage with oncology-focused healthcare networks and diagnostic laboratories.
Growing Industry Presence As a leading biotech innovator with a dedicated team of up to 200 employees, the company is well-positioned to expand sales efforts across North American healthcare providers, pharma companies, and biotech firms investing in early diagnostics.